Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.34 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.34 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.34 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19091257 | 0.92 | CARM1 (0.42) | TP53SMN1; SMN2USP2ALDH1A1LMNA | |
| SCHEMBL20332904 | 0.90 | HRH3 (0.45) | TP53SMN1; SMN2USP2ALDH1A1LMNA | |
| SCHEMBL22651218 | 0.87 | ALDH1A1 (0.55) | SMN1; SMN2ALDH1A1LMNAKDM4ECYP2C19 | |
| SCHEMBL21730543 | 0.87 | MEN1 (0.43) | TP53SMN1; SMN2USP2ALDH1A1GNAI3 | |
| SCHEMBL24040201 | 0.86 | HRH3 (0.45) | ALDH1A1LMNAKDM4E | |
| SCHEMBL23919511 | 0.82 | ALDH1A1 (0.50) | SMN1; SMN2USP2ALDH1A1LMNAHTT | |
| SCHEMBL19091175 | 0.82 | ALDH1A1 (0.39) | TP53SMN1; SMN2USP2ALDH1A1ACE2 | |
| SCHEMBL28984365 | 0.80 | SMN1; SMN2 (0.48) | TP53SMN1; SMN2USP2ALDH1A1LMNA | |
| SCHEMBL23181938 | 0.79 | HRH3 (0.41) | SMN1; SMN2 | |
| SCHEMBL18782400 | 0.78 | USP2 (0.38) | SMN1; SMN2USP2ALDH1A1LMNAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12558648-B2 | Amine compound, acid gas absorbent, method for removing acid gas, and acid gas removal apparatus | KABUSHIKI KAISHA TOSHIBA (JP) | 2026-02-24 | — | — | US | disclosed |
| US-20240307817-A1 | ACID GAS ABSORBENT, METHOD FOR REMOVING ACID GAS, AND ACID GAS REMOVAL APPARATUS | KABUSHIKI KAISHA TOSHIBA (JP) | 2024-09-19 | — | — | US | disclosed |
| US-20230104687-A1 | NOVEL AMINE COMPOUND, ACID GAS ABSORBENT, METHOD FOR REMOVING ACID GAS, AND ACID GAS REMOVAL APPARATUS | KABUSHIKI KAISHA TOSHIBA (JP) | 2023-04-06 | — | — | US | disclosed |
| CN-115805003-A | Novel amine compound, acid gas absorbent, method for removing acid gas, and acid gas removal device | 株式会社东芝 | 2023-03-17 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12558648-B2 | Amine compound, acid gas absorbent, method for removing acid gas, and acid gas removal apparatus | ADRB2, ADRA1D, HRH2 | TP53 4843/4885SMN1; SMN2 1365/4885USP2 2007/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.